Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  • B Z Alizadeh
  • P Hanifi-Moghaddam
  • P Eerligh
  • A R van der Slik
  • H Kolb
  • A V Kharagjitsingh
  • A M Pereira Arias
  • M Ronkainen
  • M Knip
  • R Bonfanti
  • E Bonifacio
  • Devendra Prasad
  • T Wilkin
  • M J Giphart
  • B P C Koeleman
  • R Nolsøe
  • Mandrup-Poulsen, Thomas
  • N C Schloot
  • B O Roep
  • DIABMARKER Study Group
We studied whether serum interferon (IFN)-gamma or interleukin (IL)-10 levels and their corresponding functional polymorphic genotypes are associated with partial remission of type 1 diabetes (T1D). A multi-centre study was undertaken in patients with newly diagnosed T1D and matched controls. T1D patients were followed for 3 months and characterized for remission status. Partial clinical remission was defined as a daily insulin dose
OriginalsprogEngelsk
TidsskriftClinical and Experimental Immunology
Vol/bind145
Udgave nummer3
Sider (fra-til)480-4
Antal sider5
ISSN0009-9104
DOI
StatusUdgivet - 1 sep. 2006

ID: 33902104